{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Activities
  • Internal Series
  • On-Demand Activities
  • CE Planning Process
  • Calendar
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
PLEASE CREATE AN ACCOUNT IF:

• You have never attended a Cedars-Sinai CE activity
• OR You are a NEW member of the Cedars-Sinai Medical Staff since August 2023

If you do NOT meet either of the criteria above, please DO NOT CREATE AN ACCOUNT:

• If you do not know which email address is used for your account, please contact the Cedars-Sinai Office of CME.
• Accounts for existing Cedars-Sinai Medical Staff (prior to August 2023) use the primary email on file with the Medical Staff Office.

For ALL USERS: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ATC
  • BSN
  • CCC-SLP
  • CCLS
  • CPhT
  • CRNA
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • LCGC
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today


4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today Banner

  • Overview
  • Faculty
  • Schedule
  • Exhibitor Registration
Add to Calendar 4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today 3/18/2023 7:30:00 AM 3/18/2023 2:00:00 PM America/Los_Angeles For More Details: https://cedars.cloud-cme.com/gicancercme23 Description: The fourth annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus. Invited faculty will present... Online and Cedars-Sinai Harvey Morse Conference Center false MM/DD/YYYY


Date & Location
Saturday, March 18, 2023, 7:30 AM - 2:00 PM PST, Online and Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA

Target Audience
Specialties - Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Hepatology, Internal Medicine, Medical Genetics, Nuclear Medicine, Oncology, Pain Management, Palliative Care, Pathology & Laboratory Medicine, Radiation Oncology, Radiology
Professions - Physician

Overview
The fourth annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus. Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.

Objectives
  1. Consider advances in biomarkers and therapy to better inform treatment decision-making for patients with gastroesophageal cancers
  2. Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence-based national guidelines for treatment planning
  3. Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside
  4. Increase knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies
  5. Identify and implement optimal strategies for managing therapy-related side effects and toxicities in patients treated with therapeutic agents
  6. Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team

Registration

In-Person
In-person-Physicians: $49
In-person-Non-physician: Free
In-person-Resident/Fellow: Free
In-person-Industry - $99.00

Virtual
Virtual-Physicians: $99
Virtual- Non-physicians: Free
Virtual-Resident/Fellow: Free

Add optional product:
Cedars-Sinai In-person Art Tour from 1p – 2p


 

Refund Policy:
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.


Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

Health and Safety Protocols
As you know, the health and safety of our community are always our top priorities at Cedars-Sinai. Participants in any event should be thoughtful about their individual risks and consider avoiding public gatherings if they are of higher risk.

Click here to review the current in-person Cedars-Sinai CME Event Protocols.



Accreditation

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

American Board of Internal Medicine (ABIM) MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (5.00 hours), ABIM MOC Part 2 (5.00 hours), Non-Physician AMA Attendance (5.00 hours)


Keywords: LIVEABIM2AMAMOC



Mitigation of Relevant Financial Relationships


Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Joan Vasquez
Cedars-Sinai Medical Center
Activity Administrator
Nothing to disclose
Faculty Photos
Jun Gong, MD
Cedars-Sinai
Course Director, Faculty
Advisor-EMD Serono (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Elsevier|Advisor-Exelixis (Relationship has ended)|Advisor-QED Therapeutics (Relationship has ended)|Advisor-Natera (Relationship has ended)|Advisor-Bayer Corporation (Relationship has ended)|Advisor-Basilea (Relationship has ended)|Advisor-HalioDx (Relationship has ended)|Advisor-Eisai, Inc.|Advisor-Janssen (Relationship has ended)|Advisor-Aveo (Relationship has ended)
Faculty Photos
Andrew E. Hendifar, MD
Cedars-Sinai
Course Director, Faculty
Consultant-Ipsen (Relationship has ended)|Consultant-Amgen|Advisor-Merck and Company, Inc.
Faculty Photos
Arsen Osipov, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Center
Faculty
PrincipalNamedInvestigator-Arcus|PrincipalNamedInvestigator-AstraZeneca|PrincipalNamedInvestigator-BioNtech|PrincipalNamedInvestigator-Bristol-Myers Squibb|PrincipalNamedInvestigator-Celgene|PrincipalNamedInvestigator-Roche|PrincipalNamedInvestigator-Helsinn|PrincipalNamedInvestigator-Puma|PrincipalNamedInvestigator-QED|PrincipalNamedInvestigator-Yiviva|Consultant-AstraZeneca|Consultant-Autem|Consultant-Boehringer Ingelheim Vetmedica GmbH|Consultant-Eisai, Inc.|Consultant-Exelixis|Consultant-Roche|Consultant-Helio|Consultant-Incyte|Consultant-Ipsen|Consultant-Newbridge|Consultant-Merck and Company, Inc.|Consultant-Novartis AG|Consultant-QED|Consultant-Servier|Consultant-Yiviva
Katelyn Atkins, MD, PhD
Cedars-Sinai
Faculty
Nothing to disclose
Tanios S. Bekaii-Saab, MD
Mayo Clinic
Faculty
Research Funding (to institution): Agios, Arys, Arcus, Atreca, Boston Biomedical, Bayer, Eisai, Celgene, Lilly, Ipsen, Clovis, Seattle Genetics, Genentech, Novartis, Mirati, Merus, Abgenomics, Incyte, Pfizer, BMS. Consulting (to institution): Ipsen, Arcus, Pfizer, Seattle Genetics, Bayer, Genentech, Incyte, Eisai, Merus, Merck KGA and Merck. Consulting (to self): Stemline, AbbVie, Boehringer Ingelheim, Janssen, Daiichi Sankyo, Natera, TreosBio, Celularity, Caladrius Biosciences, Exact Science, Sobi, Beigene, Kanaph, Astra Zeneca, Deciphera, Zai Labs, MJH Life Sciences, Aptitude Health, Illumina and Foundation Medicine IDMC/DSMB: Fibrogen, Suzhou Kintor, Astra Zeneca, Exelixis, Merck/Eisai, PanCan and 1Globe. Scientific Advisory Board: Imugene, Immuneering, Xilis, Replimune, Artiva and Sun Biopharma. Royalties: Uptodate Inventions/Patents: WO/2018/183488: HUMAN PD1 PEPTIDE VACCINES AND USES THEREOF – Licensed to Imugene WO/2019/055687: METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER CACHEXIA – Licensed to Recursion-Relationship_has_not_ended
Robert A. Figlin, MD
Cedars-Sinai
Faculty
Nothing to disclose
Srinivas Gaddam
Cedars-Sinai
Faculty
Independent ContractorResearcher-Cook Group Incorporated (Relationship has ended)
Faculty Photos
Alexandra Gangi, MD
Cedars Sinai
Faculty
Nothing to disclose
Pamela Kunz, MD
Yale School of Medicine
Faculty
Advisor-Amgen (Relationship has ended)|Advisor-Genentech, Inc. (Relationship has ended)|Consultant-Crinetics (Relationship has ended)|Speaker-Natera (Relationship has ended)|Advisor-HutchMed (Relationship has ended)|Advisor-Ipsen (Relationship has ended)|Advisor-Novartis AG|PrincipalNamedInvestigator-Novartis AG|Speaker-Isotope Technologies Munich (Relationship has ended)
Heinz-Josef Lenz, MD
Keck School of Medicine USC
Faculty
Consultant-Roche|Consultant-Bristol-Myers Squibb|Advisor-3T Bioscience|Consultant-oncocyte|Consultant-G1 Therapeutics|Consultant-Isofol|Consultant-Fulgent|Consultant-Jazz Therapeutics|Consultant-Novigenix
Mark Lewis, MD
Intermountain Healthcare
Faculty
Speaker-AstraZeneca
H. Gabriel Lipshutz, MD
Cedars-Sinai
Faculty
Consultant-Balt
Nicholas Nissen, MD
Cedars-Sinai
Faculty
Nothing to disclose
Eileen O'Reilly, MD
Memorial Sloan Kettering Center
Faculty
PrincipalNamedInvestigator-Arcus|PrincipalNamedInvestigator-AstraZeneca|PrincipalNamedInvestigator-BioNtech|PrincipalNamedInvestigator-Bristol-Myers Squibb|PrincipalNamedInvestigator-Celgene|PrincipalNamedInvestigator-Roche|PrincipalNamedInvestigator-Helsinn|PrincipalNamedInvestigator-Puma|PrincipalNamedInvestigator-QED|PrincipalNamedInvestigator-Yiviva|Consultant-AstraZeneca|Consultant-Autem|Consultant-Boehringer Ingelheim Vetmedica GmbH|Consultant-Eisai, Inc.|Consultant-Exelixis|Consultant-Roche|Consultant-Helio|Consultant-Incyte|Consultant-Ipsen|Consultant-Merck and Company, Inc.|Consultant-Newbridge|Consultant-Novartis AG|Consultant-QED|Consultant-Servier|Consultant-Yiviva
Franco Roviello, MD
University of Siena
Faculty
Nothing to disclose
Louise E J Thomson, MD
Cedars Sinai Imaging
Faculty
Nothing to disclose
Lei Zheng, MD
John Hopkins Sidney Kimmel Comprehensive Cancer Center
Faculty
PrincipalNamedInvestigator-Bristol-Myers Squibb|PrincipalNamedInvestigator-Merck and Company, Inc.|PrincipalNamedInvestigator-AstraZeneca|PrincipalNamedInvestigator-Amgen|Consultant-novarock|PrincipalNamedInvestigator-novarock (Relationship has ended)|PrincipalNamedInvestigator-Halozyme (Relationship has ended)|Consultant-ambrx (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Xilio|Advisor-QED (Relationship has ended)|Advisor-alphamab|Advisor-Biosion|Advisor-Amberstone|Consultant-Snow Lake Capital (Relationship has ended)|Consultant-Tavotek (Relationship has ended)|Consultant-Clinical trial options, LLC|Consultant-Novagenesis
Faculty Photos
Loretta Y. So, PhD
Cedars-Sinai
Nurse Planner
Nothing to disclose
Justin Byun

Planner
Nothing to disclose
Meghan Laszlo, MS
Cedars Sinai Medical Center
Planner
Nothing to disclose
Tomas M. Wagmister, MSW
Cedar Sinai
Planner
Nothing to disclose

Saturday, March 18, 2023

Registration, Breakfast & Exhibits
7:30AM - 7:55AM
Introduction
7:55AM - 8:00AM
Andrew E. Hendifar, MD
Cedars Sinai Cancer: A Health System Approach to Cancer Care
8:00AM - 8:10AM
Robert A. Figlin, MD
Molecular Landscape in CRC: Shaping the Future
8:10AM - 8:40AM
Heinz-Josef Lenz, MD
The Challenges of Treating Pancreatic Cancer.
8:40AM - 9:10AM
Eileen O'Reilly, MD
Cholangiocarcinoma and HCC
9:10AM - 9:40AM
Ghassan Abou-Alfa, MD
Break
9:40AM - 10:00AM
Role of Neoadjuvant Treatment in Pancreatic Cancer
10:00AM - 10:20AM
Lei Zheng, MD
Panel Discussion: Pancreatic Cancer Case Presentation
10:20AM - 10:45AM
Eileen O'Reilly, MD
Lei Zheng, MD
Katelyn Atkins, MD, PhD
Nicholas Nissen, MD (Moderator)
Srinivas Gaddam
Using social media to improve cancer care.
10:45AM - 11:05AM
Mark Lewis, MD
Overcoming obstacles to optimize care in Neuroendocrine tumors
11:05AM - 11:35AM
Pamela Kunz, MD
Panel Discussion: Neuroendocrine Tumors Case Presentation
11:35AM - 12:00PM
Mark Lewis, MD
Pamela Kunz, MD
H. Gabriel Lipshutz, MD
Alexandra Gangi, MD (Moderator)
Louise E J Thomson, MD
Pick Up Lunch
12:00PM - 12:10PM
Tailored Treatment for Gastric Cancer
12:10PM - 12:40PM
Franco Roviello, MD
Targeted Therapies in GI Cancer - Immunotherapy
12:40PM - 1:10PM
Tanios S. Bekaii-Saab, MD
Closing Remarks
1:10PM - 1:15PM
Optional: Cedars-Sinai In-Person Art Tour
1:15PM - 2:00PM

To view the Exhibit Prospectus, Click here for the -  Fourth Annual Cedars-Sinai Gastrointestinal Tumor Conference

2023 4th GI Cancer by Cedars-Sinai CME
Contact Us:
CME Office
Cedars-Sinai
8700 West Beverly Blvd., CME
Los Angeles, CA 90048
Phone: 3104235548
Email: [email protected]
Website: https://cedars.cloud-cme.com/gicancercme

Exhibit at this Event

Exhibitor Packages

Exhibitor Package - Gold Level Price: $2500.00
Includes:
  • Recognition as a Gold Level Supporter Exhibitor
  • Number of Exhibitor Badges: 2
  • Exhibit Location: Assigned Table Space

Deadline for order commitment is 3/15/2023 12:00:00 AM.

Exhibitor Package - Silver Level Price: $1500.00
Includes:
  • Recognition as a Silver Level Supporter Exhibitor
  • Number of Exhibitor Badges: 0
  • Exhibit Location: Posting on Meeting Sponsor Page

Deadline for order commitment is 3/15/2023 12:00:00 AM.

Exhibitor Package - Exhibit Booth Staff Price: $0.00
Includes:
  • Recognition as a Exhibitor Booth Staff Exhibitor
  • Number of Exhibitor Badges: 2
  • Exhibit Location: Assigned Table Space

Deadline for order commitment is 3/15/2023 12:00:00 AM.


CE Disclosure Form  | CE Application  | Privacy  |  Cedars-Sinai CME Homepage

Contact Us: [email protected]

        

© 2025 Cedars-Sinai. All Rights Reserved. A 501(c)(3) non-profit organization.